Assignee
GORDON ERLINDA M
US·1 granted patent·3 pending applications·0 citations·filing 2010–2021
Top patents by PatentIndex Score
4 records- 0155US8828378B2Targeted vectors for cancer immunotherapyGORDON ERLINDA M·Filed 2010·Granted Sep 9, 2014·0 cites·6 claims
- 0253US2021346520A1Methods of using intravenous rexin-g: a tumor-targeted retrovector encoding a dominant-negative cyclin g1 (ccng1) inhibitor for advanced pancreatic cancerGORDON ERLINDA M·Filed 2021·Application pending·0 cites
- 0350US2021299276A1Methods of exploiting oncogenic drivers along the human cyclin g1 pathway for cancer gene therapyGORDON ERLINDA M·Filed 2021·Application pending·0 cites
- 0449US2022184228A1Methods of promoting long-term survival of patients with advanced chemotherapy-resistant malignanciesGORDON ERLINDA M·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →